NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of Nebraska
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Georgetown University
National Cancer Institute (NCI)
Virginia Commonwealth University
SCRI Development Innovations, LLC
Roswell Park Cancer Institute
Vanderbilt-Ingram Cancer Center